FDA advisory committee

Duchenne muscular dystrophy DMD

Biotech

Capricor shares turn red as FDA announces deramiocel adcomm plan

Capricor saw its shares fall 13% as the FDA plans to hold an advisory committee to review the company's DMD hopeful.

Ben Adams May 6, 2025 8:32am

FDA Adcomm

After agony, FDA adcomm favors Stealth's ultra-rare disease drug

Oct 10, 2024 6:20pm

FDA

FDA scraps adcomm for Applied's rare disease drug

Sep 18, 2024 8:00am

speak chat talk world spread debate globe Earth

With MDMA debate spreading, Lykos CEO tries to dispel concerns

Jun 13, 2024 10:22am

brain alzheimers dementia neuroscience gears thought think

Lilly's donanemab sails through FDA meeting with 2 yes votes

Jun 10, 2024 5:11pm

setback chess beat defeat rook break

Lykos' MDMA treatment rejected by FDA committee

Jun 5, 2024 10:20am